Does Mounjaro affect your heart rate — and should you be concerned?

You notice your heart feels faster. Here is what is probably happening.

A few weeks into treatment, or the week after stepping up to a new strength, some people notice their pulse seems quicker than usual, not racing, not painful, just noticeably faster when resting. This is a recognised pattern with tirzepatide. In the SURMOUNT-1 trial, which followed nearly 2,500 adults with obesity over 72 weeks and is published in the New England Journal of Medicine, resting heart rate increases of a few beats per minute were observed in the tirzepatide groups. The changes were modest and, for the majority of participants, did not require any action.

The mechanism is not fully pinned down, but GLP-1 and GIP receptor activity is thought to influence the autonomic nervous system, which controls heart rate. The effect is separate from the cardiovascular benefits seen with this class of medicine over the longer term, more on that below.

One thing worth clearing up gently: a faster resting heart rate is not the same as a heart attack warning. The two feel different and have very different causes. A modest pulse increase alone, without chest pain, breathlessness or fainting, is not a medical emergency. That said, it is always worth mentioning to whoever is looking after your treatment, especially if it persists.

If you are curious how tirzepatide sits alongside the wider picture of Mounjaro's effects on the heart, that question has its own thorough answer.

How significant is the heart-rate change, and does it put you at risk?

For most people, the rise is small, typically fewer than ten beats per minute above their usual resting rate. That is within normal daily variation for many adults and would not be clinically significant in isolation. Palpitations (the sensation of feeling your heartbeat) are listed as a side effect in the NHS patient information for tirzepatide, which means enough trial participants reported it to warrant inclusion, but it did not affect the majority of people studied.

Context matters enormously here. The SURMOUNT programme, across its obesity and diabetes trials, involved well over ten thousand participants in total. The prevalence of meaningful cardiovascular events was low and was not linked to the heart-rate observations. Separate research is actively exploring tirzepatide's potential benefits in specific cardiac conditions (including work on tirzepatide in heart failure with preserved ejection fraction) which points in the opposite direction to harm.

People with pre-existing arrhythmias or heart conditions need a particularly careful prescriber review before starting. This is not a reason to rule out treatment, but it is exactly the kind of history that shapes the prescriber's assessment. If you have questions about how Mounjaro interacts with other aspects of your health, the general FAQ section covers many of the common ones.

When to contact your prescriber or seek help

There is a practical line worth drawing here. A mild, transient sense that your heart rate is slightly elevated (no other symptoms, resolving within days) is the kind of thing to note and mention at your next check-in. A different situation calls for prompt contact with your prescriber or GP: a heart rate that stays noticeably elevated for days, palpitations that feel strong or irregular, chest discomfort, feeling faint, or significant breathlessness.

These are not inevitably caused by tirzepatide, but they need assessment. If symptoms are severe or sudden, standard emergency guidance applies, call 999 or go to A&E. For anything less acute, your prescriber is the right first call. At nume, aftercare is available seven days a week, and a real clinician reads every message, not an automated response system.

It is also worth knowing that some other aspects of treatment can interact with how your cardiovascular system responds. Dehydration from nausea or vomiting, for instance, can raise heart rate independently of the medicine itself. Keeping fluids up during the early weeks matters. If you are thinking about alcohol alongside treatment, the picture there is worth reading, because alcohol and dehydration together can complicate things.

What your prescriber will want to know

Before starting tirzepatide, a thorough prescriber review includes your cardiac history, any medicines you currently take, and whether you have had rhythm problems in the past. This is standard clinical assessment, not bureaucracy. The same review happens before each repeat supply, because your health picture changes.

If you are currently on treatment elsewhere and thinking about transferring to a regulated pharmacy, our Mounjaro information page sets out the full clinical pathway. For anyone weighing up how the cost of private treatment fits into the decision, a clear cost comparison puts the numbers in context without pressure.

The kidneys and liver are two other areas patients frequently ask about once they start paying attention to how tirzepatide works in the body. Understanding what tirzepatide does to kidney function and its effects on the liver rounds out the picture considerably.

If you would like a prescriber to review your specific situation, starting a free consultation is the first step, no waiting list, reviewed the same working day by a GPhC-registered prescriber.